DS

Dharmendra Shukla

Active Director Director DIN 09784411
DIN 09784411 First appointment Nov 2022 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Nov 2022
Shareholding value •••• Premium profile

About Dharmendra Shukla

Data last updated:

Dharmendra Shukla is a Director at Medvyom Pharma Private Limited (since 2022). The company operates in Trading. Medvyom Pharma Private Limited reported revenue of ₹1.64 Cr (FY 2024).

DIN 09784411
Primary Designation Director
Industry Trading
First Appointment 09 Nov 2022
Oldest Company Age 5 yrs
Largest company Medvyom Pharma Private Limited · ₹1.64 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Medvyom Pharma Private Limited U51909JH2021PTC015999
Director09 Nov 20222021₹1.64 Cr (FY 2024)Active

Board colleagues of Dharmendra Shukla

NameDINCompanyDesignation
Arsh Ranjan08453225Medvyom Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Medvyom Pharma Private Limited
Premium access

Shareholding and investment profile for Dharmendra Shukla

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dharmendra Shukla

Dharmendra Shukla currently holds 1 directorship: Medvyom Pharma Private Limited (Director, since 09 Nov 2022, revenue ₹1.64 Cr (FY 2024)).

Dharmendra Shukla was first appointed on 09 Nov 2022 as Director at Medvyom Pharma Private Limited.

The current boards of Dharmendra Shukla's companies include Arsh Ranjan (Medvyom Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available